Early rhythm control strategy for AF may be cost-effective
An early rhythm control strategy for treatment of atrial fibrillation was cost-effective in a German population, according to new data from the EAST-AFNET 4 trial.“The health benefit of early rhythm control is evident. However, the cost-effectiveness of the new treatment strategy has not been evaluated so far,” Sophie Gottschalk, MSc, research fellow and PhD student in the department